Mariane Høgsbjerg Schleimann

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

Ole S. Søgaard, Mette E. Graversen, Steffen Leth et al. · PLoS Pathogens · 2015 · 514 citations · Full text

Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial

Steffen Leth, Mariane Høgsbjerg Schleimann, Sara Konstantin Nissen et al. · The Lancet HIV · 2016 · 173 citations

Vaccination, Granulocyte, Human Retrovirus +9

SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses

Line K. Vibholm, Stine Sofie Frank Nielsen, Marie H. Pahus et al. · EBioMedicine · 2021 · 166 citations · Full text

Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection

Line K. Vibholm, Mariane Høgsbjerg Schleimann, Jesper Falkesgaard Højen et al. · Clinical Infectious Diseases · 2017 · 143 citations · Full text

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

Jesper Damsgaard Gunst, Marie H. Pahus, Míriam Rosás-Umbert et al. · Nature Medicine · 2022 · 121 citations · Full text

Hiv/aids Counselling, Treatment And Prevention, Human Retrovirus +9